irena dujmovic basuroski - unc health care...knjazevac gymnasium, knjazevac, serbia 1986-1990. 5)...

1 Irena Dujmovic Basuroski

1) Personal Information:

Name: Irena Dujmovic Basuroski (formerly, Irena Dujmovic)

2) Education:

Degree Awarding institution Date Specialty

Postdoctoral

Research Fellow

Medical University of

Innsbruck, Innsbruck,

Austria

Jan/2009-

Mar/2010

Neuroimmunology

Doctor of Medical

Science

University of

Belgrade School of

Medicine Belgrade,

Serbia

Dec/2008 Neurology- Multiple

Sclerosis

Master of Medical

Science

University of

Belgrade School of

Medicine Belgrade,

Serbia

Oct/2003 Neurology- Multiple

Sclerosis

Board Certified

Neurologist

University of

Belgrade School of

Medicine, Belgrade,

Serbia

Nov/2002 Neurology

(Summa cum Laude,

GPA 5.0/5.0)

Neurology

Resident

University of

Belgrade School of

Medicine, Institute

(now- Clinic) of

Neurology, Clinical

Center of Serbia,

Belgrade, Serbia

Oct/1998-

Nov/2002

Neurology

Medical Intern University of

Belgrade School of

Medicine Clinical

Center of Serbia,

Belgrade, Serbia

Jun/1997-

Jun/1998

Medicine

MD University of

Belgrade School of

Medicine, Belgrade,

Oct/1990-

Apr 1997

Medicine

(GPA 9.8/10.0)

Curriculum Vitae


Serbia

3) Professional Experience—Employment History:

Clinical Associate Professor of Neurology (Oct/2017- present)

University of North Carolina School of Medicine at Chapel Hill, Multiple Sclerosis/

Neuroimmunology Division, North Carolina, USA

Consultant Neurologist (Jan/2016- Oct/2017)

General Hospital "Bel Medic", Belgrade, Serbia (Expertise: multiple sclerosis,

neuromyelitis optica spectrum disorders, other immune-mediated CNS disorders; part-

time employment)

Clinical Assistant Professor of Neurology (Nov/2011- Aug/2017)

University of Belgrade School of Medicine Department of Neurology, Belgrade, Serbia

Neuroimmunologist (Apr/2010- Aug/2017)

Neuroimmunology Laboratory, Clinic of Neurology, Clinical Center of Serbia, Belgrade,

Serbia (Expertise: routine cerebrospinal fluid analysis, detection of anti-aquaporin-4

antibodies, detection of autoantibodies against neuronal antigens, cerebrospinal fluid and

blood biobanking)

Consultant Neurologist (Nov/2002- Aug/2017)

Department for Immune-mediated CNS Disorders, Institute (now Clinic) of Neurology,

Clinical Center of Serbia, Belgrade, Serbia (Expertise: multiple sclerosis, neuromyelitis

optica spectrum disorders, other immune-mediated CNS disorders; full-time

employment)

Neurology Resident (Oct/1998- Nov/2002)

Institute (now Clinic) of Neurology, Clinical Center of Serbia, Belgrade, Serbia

Medical Intern (Jun/1997- Jun/1998)

University of Belgrade School of Medicine, Clinical Centre of Serbia, Belgrade, Serbia

4) Honors:

The Best Poster Prize (session-Neurology)

The 53rd

International Neuropsychiatric Pula Congress, 53rd

International

Neuropsychiatric Pula Congress, Pula, Croatia, June 2013

Top 10 Posters Prize

IX/XV Congress of Serbian Neurologists with International Participation, Belgrade,

Serbia, November 2013

The Best Poster Prize

VII/XIII Congress of Serbian Neurologists with International Participation, Kragujevac,

Serbia, September 2008


II Annual Research Prize

Serbian Ministry of Science and Technology, 2004

The Best Poster Prize

V Yugoslav Congress of Neurologists, Zlatibor, Serbia, 2000

Praises for excellent achievement during medical studies University of Belgrade School of Medicine, Belgrade, Serbia: 1992, 1994, 1995

The Best High School Student

Knjazevac Gymnasium, Knjazevac, Serbia 1986-1990.

5) Bibliography and Products of Scholarship:

Book chapters

1. Dujmovic Basuroski I, Drulovic J. A patient with a severe central nervous system

disease of unclear aethiology-brain biopsy or not? In: Neuroethics, Todorovic Z, Turza K,

Drulovic J (Editors), University of Belgrade Faculty of Medicine, Belgrade, Serbia, 43-

44, 2017. [Article in Serbian]

2. Dujmovic I. Central Pontine Myelinolysis in Alcoholism: An Osmotic Demyelination

Syndrome. In: Neuropathology Of Drug Addictions And Substance Misuse. Volume 1,

Preedy VR (Editor). Elsevier Inc, 600-609, 2016. [Article in English]

3. Drulovic J, Dujmovic I. Cerebrospinal fluid. In: Neurology, Kostic V (Editor),

Revised Edition, University of Belgrade Faculty of Medicine, Belgrade, Serbia, 113-121,

2016. [Article in Serbian]

4. Dujmovic Basuroski I, Drulovic J, Pekmezovic T. Natural course and prognosis in

multiple sclerosis. In: Multiple Sclerosis, Drulovic J (Editor), University of Belgrade

School of Medicine, Belgrade, Serbia, 32-46, 2013. [Article in Serbian]

5. Dujmovic Basuroski I, Mesaros S. Differential diagnosis of multiple sclerosis. In:

Multiple Sclerosis, Drulovic J (Editor), University of Belgrade School of Medicine,

Belgrade, Serbia, 143-158, 2013. [Article in Serbian]

6. Mesaros S, Dujmovic Basuroski I, Drulovic J. Multiple sclerosis relapse treatment.

In: Multiple Sclerosis, Drulovic J (Editor), University of Belgrade School of Medicine,


7. Drulovic J, Mesaros S, Dujmovic I, Stojsavljevic N. New concepts of multiple

sclerosis treatment with respect to heterogenous disease pathogenesis. In: Brain Decade

Lessions. Kostic V, Apostolski S (Editors), University of Belgrade School of Medicine,


Dissertation


Dujmovic Basuroski I. Early prognostic factors of clinical outcome in patients with

multiple sclerosis. Doctor of Medical Science Dissertation. University of Belgrade

School of Medicine, Belgrade, Serbia, 12/15/2008.

Refereed Papers/Articles

1. Mader S, Jeganathan V, Arinuma Y, Fujieda Y, Dujmovic I, Drulovic J, Shimizu Y,

Sakuma Y, Stern JNH, Aranow C, Mackay M, Yasuda S, Atsumi T, Hirohata S, Diamond

B. Understanding the antibody repertoire in Neuropsychiatric Systemic Lupus

Erythematosus and Neuromyelitis Optica Spectrum Disorders: do they share common

targets? Arthritis Rheumatol 2017. doi: 10.1002/art.40356. [Article in English]

2. Drulović J, Gavrilović A, Crnošija L, Kisić-Tepavčević D, Krbot Skorić M, Ivanović J,

Adamec I, Dujmović I, Junaković A, Marić G, Martinović V, Pekmezović T, Habek M.

Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian

patients with multiple sclerosis. Croat Med J 2017;58(5):342-348. [Article in English]

3. Dujmovic I, Hegen H, Paz P, Croze E, Deisenhammer F. Persistency of neutralizing

anti-interferon-β antibodies in patients with multiple sclerosis depends on antibody titers,

IgG subclasses and affinity maturation. J Interferon Cytokine Res 2017; 37: 317-

24. [Article in English]

4. Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M,

Dujmovic I, van der Flier W, Frölich L, Galimberti D, Gnanapavan S, Hemmer B, Hoff E,

Hort J, Iacobaeus E, Ingelsson M, de Jong FJ, Jonsson M, Khalil M, Kuhle J, Lleó A, de

Mendonça A, Luis Molinuevo J, Nagels G, Paquet C, Parnetti L, Roks G, Rosa-Neto P,

Scheltens P, Skårsgard C, Stomrud E, Tumani H, Visser PJ, Wallin A, Winblad B,

Zetterberg H, Duits F, Teunissen CE. Consensus guidelines for lumbar puncture in

patients with neurological diseases. Alzheimer's & Dementia: DADM 2017; 8: 111-26.

[Article in English]

5. Rakocevic-Stojanovic V, Peric S, Dujmovic I, Drulovic J, Pesovic J, Savic-Pavicevic

D. Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1

and 2. J Neuromuscul Dis 2017; 4: 89-92. [Article in English]

6. Dujmovic I, Radovanovic S, Martinovic V, Dackovic J, Maric G, Mesaros S,

Pekmezovic T, Kostic V, Drulovic J. Gait pattern in patients with different multiple

sclerosis phenotypes. Mult Scler Relat Disord 2017; 13: 13-20. [Article in English]

7. Drulovic J, Cukic M, Grgic S, Dincic E, Raicevic R, Nadj C, Toncev G, Vojinovic S,

Mesaros S, Kisic Tepavcevic D, Dujmovic I, Tadic D, Miletic-Drakulic S, Dackovic J,

Kostic S, Erakovic J, Sakalas L, Savic D, Suknjaja V, Martinovic V, Maric G,

Pekmezovic T. The impact of betaplus program on patient treatment satisfaction with

interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western

Balkan countries. Mult Scler Relat Disord 2017; 11: 56-61. [Article in English]

8. Kisic Tepavcevic D, Pekmezovic T, Dujmovic Basuroski I, Mesaros S, Drulovic J.

Bladder dysfunction in multiple sclerosis: a 6-year follow-up study. Acta Neurol Belg

2017; 117: 83-90. [Article in English]

9. Dackovic J, Pekmezovic T, Mesaros S, Dujmovic I, Stojsavljevic N, Martinovic V,

Drulovic J. The Rao's Brief Repeatable Battery in the study of cognition in different

multiple sclerosis phenotypes: application of normative data in a Serbian population.

Neurol Sci 2016; 37: 1475-81. [Article in English]

10. Trentini A, Castellazzi M, Cervellati C, Manfrinato MC, Tamborino C, Hanau S,

Volta CA, Baldi E, Kostic V, Drulovic J, Granieri E, Dallocchio F, Bellini T, Dujmovic I,

https://www.ncbi.nlm.nih.gov/pubmed/28106565


http://www.sciencedirect.com/science/article/pii/S2211034817300123

http://www.sciencedirect.com/science/article/pii/S2211034817300123






Fainardi E. Interplay between matrix metalloproteinase (MMP)-9, MMP-2 and

interleukins in multiple sclerosis patients. Dis Markers 2016; 2016: 3672353. doi:

10.1155/2016/3672353. [Article in English]

11. Dujmovic I, Demetz S, Millonig A, Deisenhammer F. The effect of fatigability on

Expanded Disability Status Scale components in multiple sclerosis. Srp Arh Celok Lek


12. Nedeljkovic U, Dackovic J, Kisic-Tepavcevic D, Dujmovic Basuroski I, Mesaros S,

Pekmezovic T, Drulovic J. Multidisciplinary rehabilitation and steroids in the

management of multiple sclerosis relapses: a randomized controlled trial. Arch Med Sci

2016; 12: 380–89. [Article in English]

13. Martinovic V, Ivanovic J, Dujmovic Basuroski I. Neurological indications for

therapeutis plasma exchange. A review. Sinapse 2016; 4: 80-4. [Article in Serbian]

14. Rodic SZ, Knezevic TI, Kisic-Tepavcevic DB, Dackovic JR, Dujmovic I, Pekmezovic

TD, Drulovic JS, Konstantinovic LM. Validation of the Serbian Version of Multiple

Sclerosis Spasticity Scale 88 (MSSS-88). PLoS One 2016; 11(1):e0147042. doi:

10.1371/journal.pone.0147042. [Article in English]

15. Milosevic E, Dujmovic I, Markovic M, Mesaros S, Rakocevic G, Drulovic J,

Stojkovic MM, Popadic D. Higher expression of IL-12Rβ2 is associated with lower risk

of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy

during 3-year follow-up. J Neuroimmunol 2015; 287: 64-70. [Article in English]

16. Drulovic J, Basic-Kes V, Grgic S, Vojinovic S, Dincic E, Toncev G, Kezic MG,

Kisic-Tepavcevic D, Dujmovic I, Mesaros S, Miletic-Drakulic S, Pekmezovic T. The

Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional

Survey. Pain Med 2015; 16: 1597-602. [Article in English]

17. Zhang X, Tao Y, Chopra M, Dujmovic-Basuroski I, Jin J, Tang Y, Drulovic J,

Markovic-Plese S. IL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-

Remitting Multiple Sclerosis. J Immunol 2015; 194: 5139-49. [Article in English]

18. Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick J, Meier

UC, Marta M, Costa GD, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano

P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H,

Rauch S, D'Alfonso S, Alvarez-Cermeño J, Kleinová P, Horáková D, Roesler R, Lauda F,

Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R,

Moll N, Khalil M, Marignier R, Dujmovic I, et al. Conversion from clinically isolated

syndrome to multiple sclerosis: A large multicentre study. Mult Scler 2015; 21: 1013-24.


19. Dujmovic I, Nikolic I, Gavric-Kezic M, Dackovic J, Mesaros S, Drulovic J. Teaching

NeuroImages: Reversible widespread brain MRI lesions in Marchiafava-Bignami disease.

Neurology 2015; 84(11): e81-2. doi: 10.1212/WNL.0000000000001373. [Article in

English]

20. Tancic-Gajic M, Vujovic S, Dujmovic I, Basta I, Ivovic M, Marina LV, Djordjevic

PB, Micic D. Acquired Hypertrichosis Lanuginosa: Typical Presentation and Unusual

Association. Arch Iran Med 2015; 18: 450-2. [Article in English]

21.Dujmovic Basuroski I. Multiple sclerosis or neuromyelitis optica: how to establish a

right diagnosis? Sinapse 2015; 4: 15-9. [Article in Serbian]

22. Tepavcevic DK, Pekmezovic T, Stojsavljevic N, Kostic J, Basuroski ID, Mesaros S,

Drulovic J. Change in quality of life and predictors of change among patients with

multiple sclerosis: a prospective cohort study. Qual Life Res 2014; 23: 1027-37. [Article

in English]


23. Nedeljkovic U, Raspopovic ED, Ilic N, Dackovic J, Dujmovic I. Endurance and

resistance training in rehabilitation of patients with multiple sclerosis.Vojnosanit Pregl


24. Gnanapavan S, Hegen H, Khalil M, Hemmer B, Franciotta D, Hughes S, Hintzen R,

Jeromin A, Havrdova E, Tumani H, Bertolotto A, Comabella M, Frederiksen J, Alvarez-

Cermeño JC, Villar L, Galimberti D, Myhr KM, Dujmovic I, Fazekas F, Ionete C, Menge

T, Kuhle J, Keir G, Deisenhammer F, Teunissen C, Giovannoni G. Guidelines for uniform

reporting of body fluid biomarker studies in neurologic disorders. Neurology 2014; 83:

1210-6. [Article in English] 25.

Kravljanac R, Martinovic V, Dujmovic I, Djuric M, Kuzmanovic M, Weinshenker BG,

Drulovic J. Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4

antibody positive paediatric patient. Mult Scler 2014; 20: 1404-6. [Article in English]

26. Drulovic J, Kostic J, Mesaros S, Dujmovic Basuroski I, Stojsavljevic N, Kisic

Tepavcevic D, Pekmezovic T. Interferon-beta and disability progression in relapsing-

remitting multiple sclerosis. Clinical Neurology and Neurosurgery 2013; 115 Suppl 1:

S65-9. [Article in English]

27. Dujmovic I, Lunn MP, Reilly MM, Petzold A. Serial cerebrospinal fluid

neurofilament heavy chain levels in severe Guillain-Barré syndrome. Muscle and Nerve


28. Rocca MA, Mesaros S, Preziosa P, Pagani E, Stosic-Opincal T, Dujmovic-Basuroski

I, Drulovic J, Filippi M. Wallerian and trans-synaptic degeneration contribute to optic

radiation damage in multiple sclerosis: a diffusion tensor MRI study. Mult Scler 2013; 19:

1610-7. [Article in English]

29. Tepavcevic DK, Pekmezovic T, Stojsavljevic N, Kostic J, Basuroski ID, Mesaros S,

Drulovic J. Predictive value of health-related quality of life in progression of disability

and depression in persons with multiple sclerosis: a 3-year study. Acta Neurol Belg


30. Teunissen C, Menge T, Altintas A, Alvarez-Cermeño JC, Bertolotto A, Berven FS,

Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D,

Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes

S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J,

Dujmovic I, Khalil M, Bartos A. Consensus definitions and application guidelines for

control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler


31.Dujmovic I, Vitas J, Zlataric N, Drulovic J. Central pontine myelinolysis in a chronic

alcoholic: clinical and brain magnetic imaging follow-up.Vojnosanit Pregl 2013; 70: 785-


32. Mesaros S, Stojsavljevic N, Dujmovic -Basuroski I, Dejanovic I, Pekmezovic T,

Drulovic J. Long-term adherence to interferon-beta treatment in a cohort of RRMS

patients in Belgrade, Serbia. Clin Neurol Neurosurg 2012; 114: 1145-8. [Article in

English]

33. Dujmovic I, Mader S, Schanda K, Deisenhammer F, Stojsavljevic N, Kostic J, Berger

T, Drulovic J, Reindl M. Temporal dynamics of cerebrospinal fluid anti-aquaporin-4

http://www.ncbi.nlm.nih.gov/pubmed/25518277


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mader%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Schanda%20K%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Deisenhammer%20F%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Stojsavljevic%20N%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kostic%20J%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Berger%20T%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Berger%20T%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Drulovic%20J%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Reindl%20M%22%5BAuthor%5D


antibodies in patients with neuromyelitis optica spectrum disorders. J Neuroimmunol


34. Dujmovic I. Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in

Multiple Sclerosis: a review. Mult Scler Int 2011, doi:10.1155/2011/767083. [Article in

English]

35. Dujmovic -Basuroski I, Pekmezovic T. Multiple sclerosis: natural disease course and

prognosis. Acta Clinica 2011; 11: 85-100. [Article in Serbian]

36. Dujmovic -Basuroski I, Mesaros S. The spectrum of multiple sclerosis mimics. Acta

Clinica 2011; 11: 101-22. [Article in Serbian]

37. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A,

Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F,

Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M. Complement

activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and

related disorders. J Neuroinflammation 2011; 8: 184. doi: 10.1186/1742-2094-8-184.


38. Dujmovic I, Deisenhammer F. Stability of cerebrospinal fluid/serum glucose ratio and

cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements.

Clin Chem Lab Med 2010; 48: 209-12. [Article in English]

39. Dujmovic I, Mangano K, Pekmezovic T, Quattrocchi C, Mesaros S, Stojsavljevic N,

Nicoletti F, Drulovic J. The analysis of IL-1 beta and its naturally occurring inhibitors in

multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II

after steroid therapy. J Neuroimmunol 2009; 207: 101-6. [Article in English]

40. Dujmovic I, Pekmezovic T, Obrenovic R, Nikolic A, Spasic M, Stojkovic MM,

Drulovic J. Cerebrospinal fluid and serum uric acid levels in patients with multiple

sclerosis. Clin Chem Lab Med 2009; 47: 848-53. [Article in English]

41. Pekmezovic T, DK Tepavcevic, Mesaros S, Dujmovic I, Stojsavljevic N, Drulovic J.

Food and dietary patterns and multiple sclerosis: a case-control study in Belgrade

(Serbia). Ital J Public Health 2009; 6: 81-7. [Article in English]

42. Drulovic J, Savic E, Pekmezovic T, Mesaros S, Stojsavljevic N, Dujmovic-Basuroski

I, Kostic J, Vasic V, Mostarica Stojkovic M, Popadic D. Expression of Th1 and Th17

cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet

mRNA predict the response to interferon-beta treatment? J Neuroimmunol 2009; 215:


43. Tepavcevic DK, Kostic J, Dujmovic Basuroski I, Stojsavljevic N, Pekmezovic T,

Drulovic J. The impact of sexual dysfunction on the quality of life measured by MSQoL-

54 in patients with multiple sclerosis. Mult Scler 2008; 14: 1131-6. [Article in English]

44. Drulovic J, Pekmezovic T, Matejic B, Mesaros S, Manigoda M, Dujmovic I,

Stojsavljevic N, Kocev N, Gavric-Kezic M, Nikic P, Dragojlovic M. Quality of life in

patients with multiple sclerosis in Serbia. Acta Neurol Scand 2007; 115: 147-52. [Article

in English]

45. Pekmezovic T, Svetel M, Maric J, Dujmovic Basuroski I, Dragasevic N, Keckarevic

M, Romac S, Kostic VS. Huntington's disease patients in Serbia: longer survival in female

patients. Eur J Epidemiol 2007; 22: 523-6. [Article in English]

46. Dujmovic I, Svetel M, Petrovic I, Stefanova E, Koprivsek K, Kozic D, Kostic V.

Reversible brain damage following acute poisoning with an organic solvent determined

by magnetic resonance. Vojnosanit Pregl 2005; 62: 487-90. [Article in Serbian]

47. Manigoda M, Dujmovic-Basuroski I, Trikic R, Drulovic J. Acute sciatic neuropathy-

"post-Saturday palsy". Srp Arh Celok Lek 2005; 133: 58-61. [Article in Serbian]

http://www.ncbi.nlm.nih.gov/pubmed?term=dujmovic%202011

http://www.ncbi.nlm.nih.gov/pubmed?term=dujmovic%202011

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Dujmovic%20I%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Deisenhammer%20F%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dujmovic%20I%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Mangano%20K%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Pekmezovic%20T%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Quattrocchi%20C%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Mesaros%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Stojsavljevic%20N%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Nicoletti%20F%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Drulovic%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dujmovic%20I%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus


http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Obrenovic%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Nikoli%C4%87%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Spasic%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Stojkovic%20MM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Drulovic%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Drulovic%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Savic%20E%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pekmezovic%20T%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mesaros%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Stojsavljevic%20N%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Dujmovic-Basuroski%20I%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Dujmovic-Basuroski%20I%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kostic%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Vasic%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mostarica%20Stojkovic%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Popadic%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Manigoda+M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Dujmovic%2DBasuroski+I%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Trikic+R%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Drulovic+J%22%5BAuthor%5D




48. Dujmovic I, Mesaros S, Pekmezovic T, Levic Z, Drulovic J. Primary progressive

multiple sclerosis: clinical and paraclinical characteristics with application of the new

diagnostic criteria. Eur J Neurol 2004; 11: 439-44. [Article in English]

49. Mesaros S, Stojsavljevic N, Dujmovic I, Mandic E, Drulovic J. The evaluation of the

long-term effect of mitoxantrone on neurological disability in patients with active

multiple sclerosis. Srp Arh Celok Lek 2004; 132: 209-13. [Article in Serbian]

50. Drulovic J, Popadic D, Mesaros S, Dujmovic I, Cvetkovic I, Miljkovic Dj,

Stojsavljevic N Pravica V, Pekmezovic T, Bogdanovic G, Jarebinski M, Mostarica

Stojkovic M. Decreased frequency of the tumor necrosis factor -308 allele (TNF2) in

Serbian patients with multiple sclerosis. Eur Neurol 2003; 50: 25-9. [Article in English]

51. Markovic M, Trajkovic V, Drulovic J, Mesaros S, Stojsavljevic N, Dujmovic I,

Mostarica Stojkovic M. Antibodies against myelin oligodendrocyte glycoprotein in the

cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci 2003; 211: 67-73. [Article

in English]

52. Miljkovic Dj, Drulovic J, Trajkovic V, Mesaros S, Dujmovic I, Maksimovic D,

Samardzic T, Stojsavljevic N, Levic Z, Mostarica Stojkovic M. Nitric oxide metabolites

and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients. Eur J Neurol


53. Sokic D, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M, Peric V,

Dragutinovic G, Levic Z. Seizures in Multiple Sclerosis. Epilepsia 2001; 42: 72-9.


54. Drulovic J, Dujmovic I, Stojsavljevic N, Mesaros S, Anđelkovic S, Miljkovic Dj,

Peric V, Dragutinovic G, Marinkovic J, Levic Z, Mostarica-Stojkovic M. Uric acid levels

in sera from patients with multiple sclerosis. J Neurol 2001; 248: 121-6. [Article in

English]

55. Drulovic J, Dujmovic I, Mesaros S, Samardzic T, Maksimovic D, Stojsavljevic N,

Levic Z, Mostarica-Stojkovic M. Raised cerebrospinal fluid nitrite and nitrate levels in

patients with multiple sclerosis: no correlation with disease activity. Mult Scler 2001; 7:


56. Stojsavljevic N, Dujmovic I, Drulovic J, Levic Z. Postural headache in patient with

spontaneous intracranial hypotension- a case report. Clinical and Experimental Neurology

2000; 5: 365-71. [Article in Serbian]

57. Drulovic J, Mesaros S, Stojsavljevic N, Apostolski S, Sokic D, Dujmovic I, Jankovic

S, Levic Z. Cladribine in the treatment of progressive multiple sclerosis: a pilot study.

Clinical and Experimental Neurology 2000; 5: 351-7. [Article in Serbian]

58. Levic Z, Dujmovic I, Pekmezovic T, Jarebinski M, Marinkovic J, Stojsavljevic N,

Drulovic J. Prognostic factors for survival in multiple sclerosis. Mult Scler 1999; 5: 171-


59. Levic Z, Dujmovic I, Drulovic J, Pekmezovic T, Jarebinski M, Stojsavljevic N.

Prognosis in multiple sclerosis. Neurol Psychiatry Brain Res 1999; 6: 181-90. [Article in

English]

60. Dujmovic I, Stojsavljevic N, Miljic P, Drulovic J, Levic Z. Thrombosis of

the transverse sinus of the brain as a manifestation of antiphospholipid syndrome. Srp Arh

Celok Lek 1999; 127: 65-9. [Article in Serbian]

61. Drulovic J, Levic Z, Dujmovic I, Stojsavljevic N, Mavra M. Oligoclonal IgG in sera

of patients with neurological disorders. Medical Investigations 1997; 31: 21-4. [Article in

Serbian]


62. Dujmovic I, Mesaros S. Micturition disturbances in multiple sclerosis patients.

Medical Youth 1996; 38: 27-31. [Article in Serbian]

63. Drulovic J, Stojsavljevic N, Dujmovic I, Sokic D, Mavra M, Levic Z. Findings

of cerebrospinal fluid in the diagnosis of multiple sclerosis. Srp Arh Cel Lek 1995; 123:

191-3. [Article in Serbian]

o Published Letters (Peer Reviewed)

1. Dujmovic I, Nikolic I, Martinovic V, Mesaros S, Drulovic J. Heroin-induced acute

longitudinally extensive transverse myelopathy. Neurol Sci 2017. doi: 10.1007/s10072-

017-3197-x. [Article in English]

2. Preziosa P, Rocca MA, Mesaros S, Meani A, Montalban X, Drulovic J, Droby A, Zipp

F, Calabrese M, Sastre-Garriga J, Dujmovic-Basuroski I, Rovira A, Filippi M. Diagnosis

of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-

2010 criteria. J Neurol Neurosurg Psychiatry 2017. doi: 10.1136/jnnp-2017-315863.

[Epub ahead of print] [Article in English]

3. Kisic-Tepavcevic D, Pekmezovic T, Trajkovic G, Stojsavljevic N, Dujmovic I, Mesaros

S, Drulovic J. Corrigendum to "Sexual dysfunction in multiple sclerosis: A 6-year follow-

up study" [J. Neurol. Sci. 358 (2015) 317-323]. J Neurol Sci 2017;372: 201. [Article in

English]

4. Dujmovic I, Jancic J, Dobricic V, Jankovic M, Novakovic I, Comabella M, Drulovic J.

Are Leber's mitochondial DNA mutations associated with aquaporin-4 autoimmunity?

Mult Scler 2016; 22: 393-4. [Article in English]

5. Rejdak K, Petzold A, Ng K, Afra J, Dujmovic I, Stelmasiak Z, Ryglewicz D,

Kwiecinski H, Grisold W, Vecsei L. Neurology training around the world: asking the

trainees. Lancet Neurol 2010; 9: 32-3. [Article in English]

6. Drulovic J, Dujmovic I, Stojsavljevic N, Tripkovic I, Apostolski S, Levic Z, Mostarica

Stojkovic M, Bonaci B, Andrejevic S. Transverse myelopathy in the antiphospholipid

antibody syndrome: pinworm infestation as a trigger? J Neurol Neurosurg Psychiatry

2000; 68: 249. [Article in English]

Other Published Articles

1. Dujmovic Basuroski I. Cerebrospinal fluid analysis for the diagnosis of multiple

sclerosis. In: National Guidelines for Good Clinical Practice: Multiple Sclerosis. Republic

of Serbia, Ministry of Health, Belgrade, Serbia, 21-23, 2013. [Article in Serbian]

2. Dujmovic Basuroski I, Nalic D, Gavric-Kezic M. Symptomatic treatment and

rehabilitation in patients with multiple sclerosis. In: National Guidelines for Good

Clinical Practice: Multiple Sclerosis. Republic of Serbia, Ministry of Health, Belgrade,

Serbia, 42-48, 2013. [Article in Serbian]

Published Abstracts

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Rejdak%20K%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Petzold%20A%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ng%20K%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Afra%20J%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Dujmovic%20I%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Stelmasiak%20Z%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ryglewicz%20D%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kwiecinski%20H%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Grisold%20W%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Vecsei%20L%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=dujmovic%20trainees


1. Cacciaguerra L, Rocca MA, Mesaros S, Radaelli M, Drulovic J, Pagani E, Martinelli

V, Dujmovic-Basuroski I, Comi G, Filippi M. Brain and spinal cord imaging features in

neuromyelitis optica spectrum disorder. Mult Scler 2017; 23 (S3): 88-89. P290. [Abstract

in English]

2. Fissolo N, Issazadeh-Navikas S, Dujmovic I, Voortman M, Khalil M, Montalban X,

Comabella M. Serpina3n: potential biomarker in patients with progressive multiple

sclerosis. Mult Scler 2017; 23 (S3): 219. P508. [Abstract in English]

3. Hidalgo de la Cruz M, Rocca MA, Valsasina P, Mesaros S, Dackovic J, Dujmovic-

Basuroski I, Drulovic J, Filippi M. Dynamic functional network connectivity in CIS

patients: a longitudinal study. Mult Scler 2017; 23 (S3): 225-226. P519. [Abstract in

English]

4. Cacciaguerra L, Pagani E, Mesaros S, Dackovic J, Dujmovic-Basuroski I, Drulovic J,

Filippi M, Rocca MS. Dynamic volumetric changes of hippocampal subfields in CIS

patients: a 2-year MRI study. Mult Scler 2017; 23 (S3): 236-237. P536. [Abstract in

English]

5. Dujmovic Basuroski I, Martinovic V, Maric G, Mesaros S, Pekmezovic T,

Weinshenker B, Drulovic J. Survival in patients with neuromyelitis optica spectrum

disorders: data from the Belgrade cohort. Mult Scler 2017; 23 (S3): 437-438. P848.

[Abstract in English]

6. Leurs CE, Twaalfhoven HAM, Witte BI, V. van Pesch V, Dujmovic I, Drulovic J,

Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez Cermeno JC, Alvarez-

Lafuente R, Hegen H, Deisenhammer F, Thouvenot E, Comabella M, Montalban X,

Vecsei L, Rajda C, Galimberti D, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G,

Jensen PE, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M,

Vanopdenbosch L, Uitdehaag BMJ, Killestein J, Bridel1 C, Teunissen C. Kappa free light

chains: an automated alternative to oligoclonal bands for CIS and MS diagnosis? Mult

Scler 2017; 23 (S3): 591-593. P1131. [Abstract in English].

7. Dujmovic Basuroski I, Martinovic V, Ivanovic J, Zegarac T, Andabaka M, Mesaros S,

Drulovic J. Maintenance therapeutic plasma exchange in patients with neuromyelitis

optica spectrum disorders. Mult Scler 2017; 23 (S3): 691. EP1297. [Abstract in English].

8. Drulovic J, Gavrilovic A, Crnosija L, Kisic-Tepavcevic D, Krbot Skoric M, IvanovicJ,

Adamec I, Dujmovic I, Junakovic A, Maric G, Martinovic V, Mesaros S, Pekmezovic T,

Habek M. Validation and cross-cultural adaptation of the Composite Autonomic

Symptom Score-31 (COMPASS-31) in Croatian and Serbian multiple sclerosis patients.

Mult Scler 2017; 23 (S3): 724-725. EP1367. [Abstract in English].

9. Crnosija L, Drulovic J, Krbot Skoric M, Nisic T, Adamec I, Gavrilovic A, Junakovic

A, Kisic-Tepavcevic D, Barun B, Andabaka M, Gabelic T, Ivanovic J, Pavicic T,

Dujmovic I, Pavlovic I, Mesaros S, Ruska B, Popovic S, Pekmezovic T. The link between

dysautonomia and depression in multiple sclerosis. Mult Scler 2017; 23 (S3): 760.

EP1443. [Abstract in English]

10. Paunovic V, Vukovic I, Kosic M, Janjetovic K, Milenkovic M, Dujmovic I, Drulovic

J, Pravica V, Trajkovic V. SQSTM1 expression and autophagy induction in multiple

sclerosis. In: The 7th Meeting of the Immunological Society of Serbia. Book of Abstracts.

Belgrade, Serbia, April 27-28, 2016: 22. [Abstract in Serbian]

11. Milosevic E, Dujmovic I, Markovic M, Mesaros S, Drulovic J, Mostarica Stojkovic

M, Popadic D. Biomarkers of treatment response in patients with relapsing-remitting

multiple sclerosis. In: The 7th Meeting of the Immunological Society of Serbia. Book of

Abstracts. Belgrade, Serbia, April 27-28, 2016: 21. [Abstract in Serbian]


12. Martinovic V, Dujmovic Basuroski I, Drulovic J. The hospital-based neuromyelitis

optica spectrum of disorders registry. In: The 7th Meeting of the Immunological Society

of Serbia. Book of Abstracts. Belgrade, Serbia, April 27-28, 2016: 18. [Abstract in

Serbian]

13. Stankovic I, Cvetkovic J, Gruden-Movsesijan A, Dujmovic I, Drulovic J, Sofronic-

Milosavljevic LJ. Serum immunoglobulins from multiple sclerosis patients bind to 45 and

58kDa Trichinella Spiralis antigens. In: The 7th Meeting of the Immunological Society of

Serbia. Book of Abstracts. Belgrade, Serbia, April 27-28, 2016: 17[Abstract in Serbian]

14. Niemantsverdriet E, Engelborghs S, Struyfs H, Blennow K, Brouns R, Comabella M,

Dujmovic I,van der Flier WM, Galimberti D, Gnanapavan S, Hemmer B, Hoff E, Hort J,

Iacobaeus E, Ingelsson M, de Jong FJ, Jonsson M, Khalil M, Kuhle J, Lleo A, de

Mendonc¸a A, Molinuevo JL, Nagels G, Paquet C, Parnetti L, Roks G, Scheltens P,

Skarsgard C, Stomrud E, Tumani H, Visser PJ, Wall A, Winblad B, Zetterberg H, Duits F,

Teunissen CE. Consensus guidelines to perform lumbar puncture for CSF sampling in

patients with neurological conditions. Alzheimers Dement 2015; 11(Suppl 7): 384.


15. 16. Dujmovic I, Gredler V, Schanda K, Mesaros S, Dackovic J, Vitas J, Pekmezovic T,

Deisenhammer F, Berger T, Drulovic J, Reindl M. Cerebrospinal fluid/serum CXCL13

ratio: a prognostic marker of conversion to clinically definite multiple sclerosis? Mult

Scler 2015; 23 (S11): 357-8. [Abstract in English]

17. Rakocevic Stojanovic V, Peric S, Pesovic J, Dujmovic Basuroski I, Jovanovic D,

Nikolic A, Savic Pavicevic D. Neuromyelitis optica in a family with both myotonic

dystrophy type 1 and type 2 mutations. In: The International Myotonic Dystrophy

Consortium Meeting Programme Abstracts. Paris, France, June 8-12, 2015. P051.


18. Drulovic J, Dackovic J, Dincic E, Dujmovic I, Kostic S, Mesaros S, Miletic-Drakulic S,

Raicevic R, Stojsavljevic N, Suknjaja V, Toncev G, Vojinovic S, Pekmezovic T. Healthcare

utilization and treatment satisfaction in persons with multiple sclerosis treated with interferon

beta-1b: a pilot sudy. Mult Scler 2015; 21(4): 531-2. [Abstract in English]

19. Dujmovic I, Mesaros S, Vitas J, Dackovic J, Srejic V, Milutinovic S, Drulovic J. The

efficacy of plasma exchange in the treatment of multiple sclerosis relapses. Eur J Neurol

2015; 22 (Suppl 1): 836. [Abstract in English]

20. Martinovic V, Dujmovic Basuroski I, Pekmezovic T, Drulovic J. Neuromyelitis

optica spectrum of disorders and autoimmune comorbidity. In: The X/XVI Congress of

the Society of Serbian Neurologists, Abstract Book. Novi Sad, Serbia, October 22-24,

2015. P69. [Abstract in Serbian]

21. Rakocevic Stojanovic V, Peric S, Pesovic J, Dujmovic Basuroski I, Nikolic A, Basta

I, Savic Pavicevic D, Drulovic J, Lavrnic D. Neuromyelitis optica and myotonic

dystrophy in a single patient: a case report. In: The X/XVI Congress of the Society of

Serbian Neurologists, Abstract Book. Novi Sad, Serbia, October 22-24, 2015. P27.

[Abstract in Serbian]

22. Vitas J, Dujmovic I, Pađen V, Dobricic V, Jankovic M, Markov M, Mesaros S,

Novakovic I, Dackovic J, Drulovic J. Recurrent encephalopathy in a patient with cerebral

autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy- a

case report. In: The X/XVI Congress of the Society of Serbian Neurologists, Abstract

Book. Novi Sad, Serbia, October 22-24, 2015. P34. [Abstract in Serbian]


23. Dujmovic Basuroski I, Jancic J, Dobricic V, Jankovic M, Novakovic I, Drulovic J.

Anti-aquaporin-4 antibodies in a patient with Leber's Hereditary Optic Neuropathy. In:

The X/XVI Congress of the Society of Serbian Neurologists, Abstract Book. Novi Sad,

Serbia, October 22-24, 2015. P48. [Abstract in Serbian]

24. Dujmovic Basuroski I, Mesaros S, Dackovic J, Vitas J, Pekmezovic T, Drulovic J.

Cerebrospinal fluid/serum CXCL13 quotient: a potential early prognostic biomarker of

conversion to clinically definite multiple sclerosis in patients with clinically isolated

syndrome. In: The X/XVI Congress of the Society of Serbian Neurologists, Abstract

Book. Novi Sad, Serbia, October 22-24, 2015. P49. [Abstract in Serbian]

25. Gavric- Kezic M, Dujmovic Basuroski I, Jeremic Lj, Drulovic J. Neuromyelitis optica

and antiphospholipid syndrome in a single patient. In: The X/XVI Congress of the Society

of Serbian Neurologists, Abstract Book. Novi Sad, Serbia, October 22-24, 2015. P50.


26. Martinovic V, Dujmovic Basuroski I, Kacar A, Drulovic J. Longitudinally extensive

transverse myelitis in a patient with West Nile virus infection. In: The X/XVI Congress of

the Society of Serbian Neurologists, Abstract Book. Novi Sad, Serbia, October 22-24,

2015. P52. [Abstract in Serbian]

27. Dackovic J, Pađen V, Mesaros S, Dujmovic Basuroski I, Martinovic V, Drulovic J.

Linear scleroderma "en coup de sabre" with associated neurologic abnormalities. In: The

X/XVI Congress of the Society of Serbian Neurologists, Abstract Book. Novi Sad, Serbia,

October 22-24, 2015. P118. [Abstract in Serbian]

28. Srejic V, Bogdanovic G, Lavrnic D, Rakocevic V, Dujmovic Basuroski I, Milutinovic

S, Miljus D. Therapeutic plasma exchange in neurological diseases. Bulletin of

Transfusion Medicine 2014; 60 (1): 121. [Abstract in Serbian]

29. Obrenovic R, Vujosevic I, Colak E, Stankovic S, Dujmovic I, Mesaros S, Savic E,

Drulovic J, Mostarica Stojkovic M. Longitudinal plasma lipid profile in multiple sclerosis

patients during two years of treatment with interferon beta. Clin Chem Lab Med 2014; 52

(Special Suppl): 1195. [Abstract in English]

30. Radovanovic S, Dujmovic I, Dackovic J, Mesaros S, Drulovic J. Gait pattern in

patients with different multiple sclerosis phenotypes. In: The 10th Congress of Clinical

Neurophysiology with International Participation, Abstract Book. Belgrade, Serbia,

October 31-November 1, 2014. S7-4. [Abstract in Serbian]

31. Martinovic V, Kravljanac R, Dujmovic Basuroski I, Drulovic J. Relapsing syndrome of

an inappropriate antidiuretic hormone secretion in an anti-aquaporin 4 positive pediatric

patient with neuromyelitis optica spectrum disorders. Eur J Neurol 2014; 21 (Suppl 1): 368.


32. Drulovic J, Nedeljkovic U, Dackovic J, Kisic-Tepavcevic D, Dujmovic Basuroski I,

Mesaros S, Pekmezovic T. The impact of the multidisciplinary rehabilitation for multiple

sclerosis relapses: a randomized controlled trial. Eur J Neurol 2014; 21 (Suppl 1): 532.


33. Dujmovic Basuroski I. Multiple sclerosis relapse treatment. Timok Medical Gazette

2014; 39 (Suppl 1): 7. [Abstract in Serbian]

34. Pekmezovic T, Basic-Kes V, Grgic S, Toncev G, Dincic E, Gavric Kezic M,

Vojinovic S, Dujmovic I, Mesaros S, Kisic-Tepavcevic D, Drulovic J. The prevalence of

pain in multiple sclerosis: a multicenter crosssectional survey. In: Abstracts of The 46th

International Danube Neurology Symposium in Cooperation with Adriatic Neurology

Forum. Becici, Montenegro, April 23 – 27, 2014. P1. [Abstract in English]

35. Markovic Plese S, Zhang X, Tao Y, Dujmovic Basuroski I, Drulovic J. IL-11 Induces


Th17-cell responses in patients with relapsing-remitting multiple sclerosis. Neurology 2014;

82 (Meeting Abstracts): P1.171. [Abstract in English]

36. Vitas J*, Dujmovic Basuroski I*, Dajak M, Mesaros S, Dackovic J, Obrenovic R,

Drulovic J. Cerebrospinal fluid and serum uric acid levels in patients with clinically isolated

syndrome suggestive of multiple sclerosis. Period Biol 2013; 115 Suppl 1: 737. [Abstract in

English]

37. Savic E, Markovic M, Drulovic J, Dujmovic Basuroski I, Mesaros S, Pravica V,

Popadic D, Mostarica Stojkovic M. mRNA expression of Th1 and Th17-related

biomarkers in patients with relapsing-remitting multiple sclerosis over three years of

treatment with interferon beta. In: Abstracts of The VI Congress of the Serbian

Neuroscience Society. Belgrade, Serbia, November 15-16, 2013. A16. [Abstract in

Serbian]

38. Gavric-Kezic M, Dujmovic Basuroski I, Djuric J, Drulovic J. Longitudinally-

extensive tranverse myelitis with brain lesions: a case report. In: The IX/XV Congress of

Serbian Neurologists with International Participation, Abstract Book. Belgrade, Serbia,

November 14-16, 2013. P107. [Abstract in Serbian]

39. Dujmovic Basuroski I, Martinovic V, Pekmezovic T, Stojsavljevic N, Mesaros S,

Dackovic J, Drulovic J. The hospital-based neuromyelitis optica spectrum of disorders

registry at the Clinic of Neurology in Belgrade. In: The IX/XV Congress of Serbian

Neurologists with International Participation, Abstract Book. Belgrade, Serbia, November

14-16, 2013. P103. [Abstract in Serbian]

40. Dackovic J, Mesaros S, Dujmovic Basuroski I, Stojsavljevic N, Vitas J, Pekmezovic

T, Drulovic J. Cognitive status in patients with multiple sclerosis. In: The IX/XV

Congress of Serbian Neurologists with International Participation, Abstract Book.

Belgrade, Serbia, November 14-16, 2013. P102. [Abstract in Serbian]

41. Mesaros S, Novkovic A, Obradovic M, Stojsavljevic N, Dujmovic Basuroski I,

Dackovic J, Pekmezovic T, Drulovic J. Interferon beta and pregnancy outcomes in

patients with multiple sclerosis. In: The IX/XV Congress of Serbian Neurologists with

International Participation, Abstract Book. Belgrade, Serbia, November 14-16, 2013. P96.


42. Petrovic M, Dackovic J, Dujmovic Basuroski I, Drulovic J. Hashimoto

encephalopathy: a case report. In: The IX/XV Congress of Serbian Neurologists with

International Participation, Abstract Book. Belgrade, Serbia, November 14-16, 2013. P91.


43. Dujmovic Basuroski I, Martinovic V, Drulovic J. Demographic, clinical and

paraclinical characteristics of patients with neuromyelitis optica spectrum disorders.

Neurol Croat 2012; 61 (Suppl 1): 24-5. [Abstract in English]

44. Dujmovic I, Mesaros S, Sumarac Z, Dackovic J, Markov M, Bogdanovic M,

Martinovic V, Drulovic J. Cerebrospinal fluid and serum chitotriosidase activity in

patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler

2013; 19(S1): 297. [Abstract in English]

45. Kuhle J, Dobson R, Topping Bestwick J, Khademi M, Sombekke M, Dalla Costa G,

Killestein J, Evdoshenko E, Lazareva N, Runia T, Zbornikova P, Horakova D, D’Alfonso

S, Thouvenot E, Moll N, Hegen H, Rauch S, Khalil M, Fuchs S, Lindberg R.L.P, Derfuss

T, Llufriu S, Franciotta D, Roesler R, Lauda F, Rajda C, Drulovic J, Menge T, Kieseier

BC, Avsar T, Marignier R, Malmestrom C, Myhr KM, Wergeland S, Annibali V, Romano

S, Carra A, Laroni A, Frederiksen JL, Larsson HB, Uccelli A, Martinez AD, Salvetti M,


Torkildsen O, LyckeJ, Confavreux C, Rejdak K, Bosca I, Brassat D, Scarpini E, Fenoglio

C, Galimberti D, Siva A, Hartung H P, Dujmovic I, Vecsei L, Tumani H, Bergamaschi R,

Colombo E, Villoslada P, Saiz A, Enzinger C, Kappos L, Deisenhammer F, Alvarez-

Cermeno JC, Villar L, Pelletier J, Lehmann S, Castelnovo G, Barizzone N, Leone M,

Havrdova E, Trojano M, Iaffaldano P, Direnzo V, Comabella M, Tintore M, Montalban

X, Hintzen R, Lapin S, Teunissen C, Piehl F, Olsson T, Furlan R, Martinelli V, Comi G,

Ramagopalan S, Giovannoni G. Multivariate clinically isolated syndrome (CIS) risk

factor study: towards individual prognosis and treatment indication in CIS. Mult Scler

2013; 19(S1): 33. [Abstract in English]

46. Dujmovic Basuroski I, Pekmezovic T, Drulovic J. Long-term follow-up of benign

multiple sclerosis in Belgrade, Serbia: Demographic and clinical characteristics. Eur J

Neurol 2011;18 (Suppl 2): 269. [Abstract in English]

47. Dujmovic I, Walchshofer R, Hölzl M, Hegen H, Paz P, Croze E, Deisenhammer F.

Antibody binding properties of different interferon beta preparations: a comparative study

of antibody titres and binding affinity. Mult Scler 2011; 17: S424. [Abstract in English]

48. Dujmovic Basuroski I, Paz P, Croze E, Deisenhammer F. The persistency of

neutralizing antibodies to interferon beta depends on affinity maturation and IgG4:

Longitudinal assessment in multiple sclerosis patients treated with different preparations.

Neurology 2011; 76 (Meeting Abstract): P01.184. [Abstract in English]

49. Marjanovic I, Basta I, Dujmovic Basuroski I, Peric S, Stevic Z, Rakocevic-Stojanovic

V, Lavrnic D. Neuromyelitis optica in a patient with myasthenia gravis: a case report. In:

The VIII/XIV Congress of Serbian Neurologists, Abstract Book. Kopaonik, Serbia,

September 29- October 2, 2011. 18E. [Abstract in Serbian]

50. Dujmovic Basuroski I, Mader S, Schanda K, Stojsavljevic N, Deisenhammer F,

Reindl M, Berger T, Drulovic J. Anti-aquaporin-4 antibodies in patients with

neuromyelitis optica spectrum disorders. In: The VIII/XIV Congress of Serbian

Neurologists, Abstract Book. Kopaonik, Serbia, September 29- October 2, 2011. 18D.


51. Dujmovic Basuroski I, Vitas J, Zlataric N, Drulovic J. A persisting "trident sign" in a

chronic alcoholic with central pontine myelinolysis: a case report. In: The VIII/XIV

Congress of Serbian Neurologists, Abstract Book. Kopaonik, Serbia, September 29-

October 2, 2011. 15D. [Abstract in Serbian]

52. Dujmovic Basuroski I, Stojsavljevic N, Mesaros S, Drulovic J. Neuromyelitis optica

in a patient with systemic lupus erythematosus. In: The VIII/XIV Congress of Serbian



53. Mesaros S, Stojsavljevic N, Dejanovic I, Dujmovic Basuroski I, Pekmezovic T,

Drulovic J. Long-term adherence to interferon beta treatment in patients with multiple

sclerosis in Belgrade In: The VIII/XIV Congress of Serbian Neurologists, Abstract Book.

Kopaonik, Serbia, September 29- October 2, 2011. 10D. [Abstract in Serbian]

54. Savic J, Dujmovic Basuroski I, Vitas J, Petrovic D, Mesaros S, Stojsavljevic N,

Dackovic J, Bogdanovic G, Drulovic J. Therapeutic plasma exchange in multiple sclerosis

relapse treatment. In: The VIII/XIV Congress of Serbian Neurologists, Abstract Book.

Kopaonik, Serbia, September 29- October 2, 2011. 7D. [Abstract in Serbian]

55. Dujmovic Basuroski I, Pekmezovic T, Drulovic J. Demographic and clinical

characteristics of patients with relapsing-remitting multiple sclerosis after 25 years of

follow-up. In: The VIII/XIV Congress of Serbian Neurologists, Abstract Book. Kopaonik,


Serbia, September 29- October 2, 2011. 6D. [Abstract in Serbian]

56. Drulovic J, Pekmezovic T, Mesaros S, Dujmovic Basuroski I, Stojsavljevic N, Savic

J, Marjanovic I, Kisic-Tepavcevic D, Grgic S, Gavric-Kezic M, Toncev G. Pain in

multiple sclerosis: a multicenter study. In: The VIII/XIV Congress of Serbian



57. Kisic-Tepavcevic D, Kostic J, Stojsavljevic N, Dujmovic Basuroski I, Mesaros S,

Pekmezovic T, Drulovic J. Smoking as a risk factor for disability progression in multiple

sclerosis: a six-year panel study. In: The VIII/XIV Congress of Serbian Neurologists,

Abstract Book. Kopaonik, Serbia, September 29- October 2, 2011. 2D. [Abstract in

Serbian]

58. Mesaros S, Stojsavljevic N, Dujmovic Basuroski I, Pekmezovic T, Drulovic J. Long-

term adherence to interferon beta treatment in a cohort of relapsing-remitting multiple

sclerosis patients in Belgrade, Serbia. Mult Scler 2010; 16: S162-3. [Abstract in English]

59. De Gennaro R, Groppo E, Gentile M, Caniatti M, Cesnik E, Fazio P, Simioni V,

Govoni V, Satta W, Pekmezovic T, Drulovic J, Dujmovic Basuroski I, Boiko A,

Smirnova N, Casetta I, Granieri E. Environmental risk factors in multiple sclerosis in

Ferrara, Russia, Sardinia and Serbia: a multicentric case-control study and a comparison

among genetically distinct populations. Neurol Sci 2010; 31: S384. [Abstract in English]

60. De Gennaro R, Baldi E, Lauria G, Pekmezovic T, Drulovic J, Dujmovic Basuroski I,

Ramponi V, Gentile M, Casetta I, Granieri E. Natural history of relapsing-remitting

multiple sclerosis: two cohorts of patients in Emilia Romagna and in Serbia treated and

untreated with immunomodulatory therapies, IFN beta and COP-1. Neurol Sci 2010; 31:

S383-4. [Abstract in English]

61. Dujmovic I, Mader S, Schanda K, Deisenhammer F, Stojsavljevic N, Kostic J, Berger

T, Drulovic J, Reindl M. Serum and cerebrospinal fluid AQP4-IgG in patients with

neuromyelitis optica spectrum disorders: a follow-up study in six patients. Eur J Neurol


62. Dujmovic I, Drulovic J, Bogdanovic G. Therapeutic plasma exchange in the treatment of

severe multiple sclerosis relapse- a case report. Bulletin of Transfusion Medicine 2010; 56:

189. [Abstract in Serbian]

63. Pekmezovic T, Kisic Tepavcevic D, Stojsavljevic N, Kostic J, Dujmovic Basuroski I,

Mesaros S, Drulovic J. Value of health-related quality of life to predict disability and

depression in multiple sclerosis patients. A 3-year cohort study in Serbia In: Abstracts of

the 41st

Danube Symposium for Neurological Sciences and Continuing Education

Workshop Cochrane Neurological Network. Linz, Austria, October 14-17, 2009. P11/01.


64. Kisic Tepavcevic D, Stojsavljevic N, Mesaros S, Dujmovic Basuroski I, Kostic J,

Pekmezovic T, Drulovic J. Quality of life in patients with multiple sclerosis: the impact of

depression, fatigue and disability. Eur J Neurol 2009; 19 (Suppl 3): S260. [Abstract in

English]

65. Dujmovic Basuroski I, Deisenhammer F. Affinity maturation of antibodies against

interferon beta in patients with multiple sclerosis treated with interferon beta 1-a. Mult

Scler 2009; 15 (Suppl 2): S244. [Abstract in English]

66. Kisic Tepavcevic D, Kostic J, Stojsavljevic N, Dujmovic Basuroski I, Mesaros S,

Pekmezovic T, Drulovic J. Health-related quality of life as a predictor for change in

disability in multiple sclerosis patients: a 3-year follow-up study. Mult Scler 2009; 15

(Suppl 2): S267. [Abstract in English]


67. Drulovic J, Savic E, Pekmezovic T, Mesaros S, Stojsavljevic N, Dujmovic Basuroski

I, Kostic J, Mostarica Stojkovic M, Popadic D. T-bet messenger RNA as a potential

prognostic marker of treatment response to interferon beta in relapsing-remitting multiple

sclerosis. Mult Scler 2009; 15 (Suppl 2): S236. [Abstract in English]

68. Kostic J, Drulovic J, Stojsavljevic N, Kisic Tepavcevic D, Pekmezovic T, Mesaros S,

Dujmovic Basursoki I. The impact of cogntive impairment on the quality of life in

patients with multiple sclerosis. Mult Scler 2009; 15 (Suppl 2): S226-7. [Abstract in

English]

69. Dujmovic Basuroski I, Mesaros S, Stojsavljevic N, Pekmezovic T, Drulovic J, Levic

Z. Prognostic factors for survival in multiple sclerosis. Mult Scler 2009; 15 (Suppl 2):

S157. [Abstract in English]

70. Savic J, Kisic-Tepavcevic D, Kostic J, Stojsavljevic N, Dujmovic Basuroski I,

Mesaros S, Pekmezovic T, Drulovic J. The impact of bladder dysfunction on the quality

of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler 2009; 15

(Suppl 2): S51. [Abstract in English]

71. Pekmezovic T, Stojsavljevic N, Mesaros S, Dujmovic Basuroski I, Kisic Tepavcevic

D, Mandic G, Savic J, Kostic J, Drulovic J. Incidence of multiple sclerosis in Belgrade,

Serbia. Twenty years of follow-up. Mult Scler 2009; 15 (Suppl 2): S43. [Abstract in

English]

72. Stojsavljevic N, Dujmovic -Basuroski I, Mesaros S, Gavric-Kezic M, Kostic J,

Pekmezovic T, Drulovic J. Interferon-beta-1b treatment in multiple sclerosis: our

experience. In: The VII/XIII Congress of Serbian Neurologists with International

Participation, Abstract Book. Kragujevac, Serbia, September 11-14, 2008. MS15.


73. Kostic J, Pekmezovic T, Stojsavljevic N, Kisic D, Dujmovic I, Drulovic J. The impact

of clinical disease characteristics on cognitive status in patients with multiple sclerosis. In:

The VII/XIII Congress of Serbian Neurologists with International Participation, Abstract

Book. Kragujevac, Serbia, September 11-14, 2008. MS14. [Abstract in Serbian]

74. Kostic J, Dujmovic Basuroski I, Stojsavljevic N, Kisic Tepavcevic D, Pekmezovic T,

Drulovic J. Immunomodulatory treatment effects on cognitive functions in patients with

multiple sclerosis. In: The VII/XIII Congress of Serbian Neurologists with International



75. Kostic J, Pekmezovic T, Stojsavljevic N, Kisic D, Dujmovic I, Drulovic J. Cognitive

dysfunction and quality of life in patients with multiple sclerosis. In: The VII/XIII


Kragujevac, Serbia, September 11-14, 2008. MS12. [Abstract in Serbian]

76. Dujmovic Basuroski I, Stojsavljevic N, Mesaros S, Gavric-Kezic M, Kostic J,

Pekmezovic T, Drulovic J. Interferon-beta-1a treatment in multiple sclerosis: our

experience. In: The VII/XIII Congress of Serbian Neurologists with International



77. Dujmovic Basuroski I, Obrenovic R, Pekmezovic T, Drulovic J. Cerebrospinal fluid

uric acid levels in patients with multiple sclerosis. In: The VII/XIII Congress of Serbian

Neurologists with International Participation, Abstract Book. Kragujevac, Serbia,

September 11-14, 2008. MS08. [Abstract in Serbian]

78. Dujmovic Basuroski I, Pekmezovic T, Drulovic J. Early prognostic factors in multiple

sclerosis. In: The VII/XIII Congress of Serbian Neurologists with International




79. Dujmovic Basuroski I, Mangano K, Pekmezovic T, Quattrochi C, Mesaros S,

Stojsavljevic N, Nicoletti F, Drulovic J. Interleukin 1-beta and its antagonists in multiple

sclerosis. In: The VII/XIII Congress of Serbian Neurologists with International



80. Kisic Tepavcevic D, Kostic J, Stojsavljevic N, Dujmovic Basuroski I, Pekmezovic T,

Drulovic J. Sexual dysfunction in patients with multiple sclerosis. In: The VII/XIII


Kragujevac, Serbia, September 11-14, 2008. A74. [Abstract in Serbian]

81. Marjanovic I, Kostic J, Stojsavljevic N, Dujmovic Basuroski I, Toncev G, Gavric M,

Pekmezovic T, Drulovic J. Correlation of the chronic pain with clinical characteristics of

multiple sclerosis. J Neurol 2008; 255(Suppl 2): 80-1. [Abstract in English]

82. Kostic J, Drulovic J, Pekmezovic T, Stojsavljevic N, Kisic-Tepavcevic D, Dujmovic

Basuroski I. Relationship between cognitive functioning and quality of life in MS

patients. Mult Scler 2007; 13(Suppl 2): S236-7. [Abstract in English]

83. Pekmezovic T, Kostic M, Kisic-Tepavcevic D, Stojsavljevic N, Dujmovic-Basuroski

I, Drulovic J. Health-related quality of life among care-givers of people with multiple

sclerosis in Belgrade (Serbia). Mult Scler 2007; 13(Suppl 2): S266. [Abstract in English]

84. Stojsavljevic N, Dujmovic-Basuroski I, Kisic-Tepavcevic D, Kostic J, Pekmezovic T,

Drulovic J. The influence of depression, anxiety and fatigue on the health-related quality

of life in Serbian patients with multiple sclerosis. Mult Scler 2007; 13 (Suppl 2): S265-6.


85. Dujmovic I, Stojsavljevic N, Jovicic V, Marjanovic I, Drulovic J. Neurosyphilis with

recurrent neurological episodes mimicking multiple sclerosis- a case report. Eur J Neurol


86. Kisic Tepavcevic D, Kostic J, Stojsavljevic N, Dujmovic Basuroski I, Pekmezovic T,

Drulovic J. Sexual dysfunction in multiple sclerosis is related to quality of life: a 3-year

follow-up study in Belgrade (Serbia). Eur J Neurol 2007; 14 (Suppl 1): 106. [Abstract in

English]

87. Drulovic J, Pekmezovic T, Mesaros S, Dujmovic I, Stojsavljevic N, Nikic P, Gavric

M, Dragojlovic M, Drakulic S, Manigoda M, Kocev N. Quality of life in patients with

multiple sclerosis from Serbia. Mult Scler 2004; 10 (Suppl 2): S129. [Abstract in English]

88. Drulovic J , Pekmezovic T, Mesaros S, Dujmovic I, Stojsavljevic N, Nikic P, Gavric

M, Dragojlovic M, Drakulic S, Manigoda M, Kocev N. Quality of life assessment in

patients with multiple sclerosis using the SF-36 questionnaire. In: The XII Congress of

Neurologists of Serbia and Montenegro with International Participation, Abstract Book.

Novi Sad, Serbia, October 6-10, 2004. 229. [Abstract in Serbian]

89. Dujmovic I, Smiljkovic P, Manigoda M, Drulovic J. Primary angiitis of the central

nervous system- a case report. In: The IV Meeting of the Yugoslav Society of Allergology

and Clinical Immunology, Abstract Book. Belgrade, Serbia, March 28-30, 2003. P62.


90. Stevic Z, Nikolic A, Blagojevic D, Pavlovic G, Lavrnic D, Dujmovic I, Obrenovic R,

Apostolski S, Spasic MB. Levels of uric acid in cerebrospinal fluid and serum of patients

with sporadic ALS. ALS 2001; 2 (Suppl 2): 136. [Abstract in English]

91. Dujmovic I, Stojsavljevic N, Knezevic S, Trikic R, Keckarevic D, Drulovic J,

Apostolski S. The association of Charcot-Marie Tooth-1a and transitory central nervous


system inflammation mimicking spinocerebellar ataxia- case report. Lekarsky obzor

2003; 52 (Suppl2): S11-2. [Abstract in English]

92. Dujmovic I, Mesaros S, Pekmezovic T, Drulovic J. Primary progressive multiple

sclerosis: clinical and paraclinical characteristics with application of the new diagnostic

criteria. In: Book of Abstracts of the 35th

International Danube Symposium for

Neurological Sciences & Continuing Education. Belgrade, Serbia; September 11-14,

2003. S25. [Abstract in English]

93. Pekmezovic T, Drulovic J, Stojsavljevic N, Mesaros S, Dujmovic Basuroski I,

Smiljkovic T, Medic S, Djordjevic-Obradovic D, Pecic-Savic O, Kisic D, Jarebinski M,

Levic Z. The occurence of multiple sclerosis in Belgrade population. In: Book of

Abstracts of the 35th

International Danube Symposium for Neurological Sciences &

Continuing Education. Belgrade, Serbia; September 11-14, 2003. P167. [Abstract in

English]

94. Drulovic J, Popadic D, Dujmovic I, Mesaros S, Cvetkovic I, Miljkovic Dj, Mostarica

Stojkovic M. Decreased frequency of the tumor necrosis factor α-308 allele (TNF2) in

Serbian patients with multiple sclerosis. In: Programme and Abstracts of the 34th

International Danube Symposium for Neurological Sciences and Continuing Education.

Bratislava, Slovak Republic, August 28-31, 2002. pp 76. [Abstract in English]

95. Dujmovic I, Mesaros S, Obrenovic R, Mostarica Stojkovic M, Drulovic J.

Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis. In:

Programme and Abstracts of the 34th International Danube Symposium for Neurological

Sciences and Continuing Education. Bratislava, Slovak Republic, August 28-31, 2002. pp

34-5. [Abstract in English]

96. Markovic M, Trajkovic V, Mesaros S, Dujmovic I, Mostarica Stojkovic M, Drulovic

J. Antibodies against myelin oligodendrocyte glycoprotein (MOG) in cerebrospinal fluid

of multiple sclerosis patients-association with clinical disease activity. J Neuroimmunol

2001; 118: P396. [Abstract in English]

97. Mesaros S, Drulovic J, Stojsavljevic N, Sokic D, Mandic E, Dujmovic I, Levic Z.

Impact of Mitoxantrone on Neurologic Disability in Active Multiple Sclerosis Patients. J

Neurol Sci 2001; 187: S454-5. [Abstract in English]

98. Dujmovic I, Drulovic J, Mesaros S, Stojsavljevic N, Levic Z. Demographic, Clinical

and Paraclinical Characteristics of Primary-Progressive Multiple Sclerosis. J Neurol Sci

2001; 187: S340. [Abstract in English]

99. Drulovic J, Miljkovic Dj, Trajkovic V, Mesaros S, Stojsavljevic N, Dujmovic I,

Mostarica Stojkovic M. Negative correlation between the levels of nitric oxide and

interleukin-6 in CSF from MS patients. Mult Scler 2001; 7 (Suppl 1): S117. [Abstract in

English]

100. Drulovic J, Samardzic T, Maksimovic D, Dujmovic I, Mesaros S, Mostarica-

Stojkovic M. Cerebrospinal fluid nitrite and nitrate levels in patients with multiple

sclerosis. Rev Neurol 2000; Suppl 3: 3S82. [Abstract in English]

101. Miljkovic Dj, Dujmovic I, Mesaros S, Stojsavljevic N, Drulovic J, Mostarica-

Stojkovic M, Levic Z. Interleukin-6 in the cerebrospinal fluid from patients with multiple

sclerosis. Rev Neurol 2000; Suppl 3: 3S85. [Abstract in English]

102. Levic Z, Drulovic J, Stojsavljevic N, Dujmovic I, Mesaros S. A clinical study of

primary progressive multiple sclerosis. Rev Neurol 2000; Suppl 3:3S138. [Abstract in

English]

103. Mesaros S, Drulovic J, Stojsavljevic N, Dujmovic I, Levic Z. Symptomatic treatment


in multiple sclerosis. In: The V Yugoslav Congress of Neurologists, Abstract Book.

Zlatibor, Serbia, May 31–June 03, 2000. pp 35. [Abstract in Serbian]

104. Dujmovic I, Drulovic J, Stojsavljevic N, Bonaci B, Andrejevic S, Levic Z .

Antiphospholipid antibody syndrome: report of three cases. In: The V Yugoslav Congress

of Neurologists, Abstract Book. Zlatibor, Serbia, May 31–June 03, 2000. pp 99. [Abstract

in Serbian]

105. Drulovic J, Mostarica Stojkovic M, Levic Z, Popadic D, Stojsavljevic N, Mesaros S,

Dujmovic I, Bogdanovic G, Pravica V, Pekmezovic T, Jarebinski M . Tumor necrosis

factor -308 allele (TNF2) polymorphism in patients with multiple sclerosis. In: The V

Yugoslav Congress of Neurologists, Abstract Book. Zlatibor, Serbia, May 31–June 03,

2000. pp 117. [Abstract in Serbian]

106. Mesaros S, Drulovic J, Levic Z, Stojsavljevic N, Mandic E, Dujmovic I. Clinical

effects of mitoxantrone in the treatment of multiple sclerosis. In: The V Yugoslav

Congress of Neurologists, Abstract Book. Zlatibor, Serbia, May 31–June 03, 2000. pp

121. [Abstract in Serbian]

107. Peric V, Drulovic J, Stojsavljevic N, Mesaros S, Dujmovic I, Dragutinovic G, Levic

Z, Ružic Z. T1-weighted hypointense brain MRI lesions in patients with multiple

sclerosis. In: The V Yugoslav Congress of Neurologists, Abstract Book. Zlatibor, Serbia,

May 31–June 03, 2000. pp 122. [Abstract in Serbian]

108. Stojsavljevic N, Levic Z, Drulovic J, Mesaros S, Dujmovic I, Sokic D, Peric V,

Dragutinovic G. Brain MRI findings in patients with vitamin B12 deficiency. In: The V

Yugoslav Congress of Neurologists, Abstract Book. Zlatibor, Serbia, May 31–June 03,

2000. pp 124. [Abstract in Serbian]

109. Stojsavljevic N, Drulovic J, Miljkovic Đ, Popadic D, Mesaros S, Dujmovic I, Levic

Z, Mostarica-Stojkovic M. Tumor necrosis factor - levels in sera of patients with vitamin

B12 deficiency. In: The 3rd Congress of the Yugoslav Society of Allergology and Clinical

Immunology, Abstract Book. Belgrade, Serbia, November 2-5, 2000. Po 39. [Abstract in

Serbian]

110. Miljkovic Dj, Dujmovic I, Mesaros S, Stojsavljevic N, Drulovic J, Mostarica-

Stojkovic M, Levic Z. Cerebrospinal fluid interleukin-6 levels in patients with multiple

sclerosis. In: The 3rd Congress of the Yugoslav Society of Allergology and Clinical

Immunology, Abstract Book. Belgrade, Serbia, November 2-5, 2000. Po 29. [Abstract in

Serbian]

111. Mesaros S, Popadic D, Drulovic J, Lavrnic D, Stojsavljevic N, Dujmovic I,

Apostolski S, Levic Z, Mostarica-Stojkovic M . Interferon- production in peripheral

blood mononuclear cells in patients with multiple sclerosis. In: The 3rd Congress of the

Yugoslav Society of Allergology and Clinical Immunology, Abstract Book. Belgrade,

Serbia, November 2-5, 2000. Po 28. [Abstract in Serbian]

112. Dujmovic I, Drulovic J, Samardžic T, Maksimovic D, Mesaros S, Stojsavljevic N,

Levic Z, Mostarica-Stojkovic M. Elevated cerebrospinal fluid nitrite and nitrate levels in

patients with multiple sclerosis. In: The 3rd Congress of the Yugoslav Society of

Allergology and Clinical Immunology, Abstract Book. Belgrade, Serbia, November 2-5,

2000. Po 19. [Abstract in Serbian]

113. Drulovic J, Dujmovic I, Stojsavljevic N, Mesaros S, Andjelkovic S, Miljkovic Dj,

Levic Z, Mostarica-Stojkovic M. Serum uric acid levels are reduced in patients with

clinically active multiple sclerosis. In: The 3rd Congress of the Yugoslav Society of


Allergology and Clinical Immunology, Abstract Book. Belgrade, Serbia, November 2-5,

2000. Or 10. [Abstract in Serbian]

114. Popadic D, Drulovic J, Dujmovic I, Mesaros S, Stojsavljevic N, Levic Z, Mostarica-

Stojkovic M. TNF2 allele frequency in patients with multiple sclerosis. In: The 3rd

Congress of the Yugoslav Society of Allergology and Clinical Immunology, Abstract

Book. Belgrade, Serbia, November 2-5, 2000. Po 14. [Abstract in Serbian]

115. Sokic D, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M, Peric V,

Dragutinovic G, Vojvodic N, Levic Z. Seizures in multiple sclerosis. Epilepsia 2000; 41:

121. [Abstract in English]

116. Drulovic J, Popadic D, Mostarica-Stojkovic M, Levic Z, Mesaros S, Dujmovic I,

Stojsavljevic N, Pravica V. Tumor necrosis factor -308 polymorphism in multiple

sclerosis. Eur J Neurol 1999; 6 (Suppl 3): 101. [Abstract in English]

117. Drulovic J, Dujmovic I, Mostarica-Stojkovic M, Stojsavljevic N, Anđelkovic S,

Mesaros S, Levic Z. Uric acid levels in serum from patients with multiple sclerosis. Mult

Scler 1999; 5 (Suppl 1): S85. [Abstract in English]

118. Mesaros S, Levic Z, Drulovic J, Stojsavljevic N, Dujmovic I, Mandic E. The

treatment of chronic progressive multiple sclerosis. In: Abstracts of the 12th Thessaloniki

Conference of the South-East European Society for Neurology and Psychiatry.

Thessaloniki, Greece, September 30- October 1, 1998. pp 104. [Abstract in English]

119. Drulovic J, Popadic D, Mostarica-Stojkovic M, Levic Z, Mesaros S, Dujmovic I,

Stojsavljevic N, Pravica V. Tumor necrosis factor -308 polymorphism in familial

multiple sclerosis. Mult Scler 1998; 4: 356. [Abstract in English]

120. Mesaros S, Levic Z, Drulovic J, Stojsavljevic N, Dujmovic I. Treatment of multiple

sclerosis with mitoxantrone. Mult Scler 1998; 4: 387. [Abstract in English]

121. Levic Z, Drulovic J, Dujmovic I, Pekmezovic T, Stojsavljevic N, Mesaros S,

Jarebinski M. Prognostic factors in multiple sclerosis. Re-evaluation after 22-years of

follow-up. Mult Scler 1997; 3: 281. [Abstract in English]

122. Milicevic S, Dujmovic I, Knezevic N. Influence of colorectal cancer resection into

serum gastrin levels. In: Book of Abstracts of the 2nd

International Student Congress of

Medical Sciences. Izmir, Turkey, September 17-20, 1996. pp 69. [Abstract in English]

123. Dujmovic I, Pavlov S, Ivetic V. Isoelectric focusing in the diagnosis of multiple

sclerosis. In: Abstract Book of the 20th

International Medical Students’ Scientific

Congress. Ohrid, Macedonia, May 10-13, 1996. P29. [Abstract in English]

124. Milicevic S, Dujmovic I, Marinkovic M, Velickovic I, Ostojic P. The new structure

of rats’ spinal cord found with the coloring method of May-Grunwald-Giemsa. In:

Abstract Book of the 20th

International Medical Students’ Scientific Congress. Ohrid,

Macedonia, May 10-13, 1996. P26. [Abstract in English]

125. Ivetic V, Radic DM, Maricic Z, Dujmovic I. Diagnosis of liver haemangioma by

“blood-pool” scintigraphy. In: Abstract Book of the 20th

International Medical Students’

Scientific Congress. Ohrid, Macedonia, May 10-13, 1996. P20. [Abstract in English]

126. Milicevic S, Dujmovic I, Marinkovic M, Velickovic I, Ostojic P. Acute gastro-

intestinal bleeding caused by helicobacter pylori. In: Abstract Book of the 20th

International Medical Students’ Scientific Congress. Ohrid, Macedonia, May 10-13, 1996.

P15. [Abstract in English]

127. Pavlov S, Dujmovic I. Sepsis in patients with pemphigus vulgaris. In: Abstract Book

of the 20th

International Medical Students’ Scientific Congress. Ohrid, Macedonia, May

10-13, 1996. P11. [Abstract in English]

128. Jovicic BM, Dujmovic I. The influence of mass media on the student population. In:


Volume of Abstracts of the 2nd

European Medical Students’ Symposium. Thessaloniki,

Greece, May 4-5, 1996. P13. [Abstract in English]

129. Dujmovic I, Drulovic J. Serum oligoclonal immunoglobulin G in patients with

neurological diseases. In: Volume of Abstracts of the 2nd

European Medical Students’

Symposium. Thessaloniki, Greece, May 4-5, 1996. pp105. [Abstract in English]

130. Dujmovic PI. Treatment of lumbar-puncture-headache with epidural injection of

autologous blood. In: Program and Abstracts of the 22nd

Eastern Student Research Forum.

Miami, Florida, USA 199, February 21-24, 1996. N17. [Abstract in English]

131. Vranes B, Dujmovic I, Durutovic O. Birthweight and Chlamydia Trachomatis

Infection in Pregnancy. In: Abstracts of the VI EMSA International Scientific

Symposium. Antwerp, Belgium, April 17-19, 1996. [Abstract in English]

132. Anđelkov K, Popovic R, Dujmovic I. Frequency of epilepsy in chronic alcoholics.

In: Abstracts of the VI EMSA International Scientific Symposium. Antwerp, Belgium,

April 17-19, 1996. [Abstract in English]

133. Dujmovic I, Andjelkov K. Bladder dysfunction in multiple sclerosis. In: Abstracts of

the VI EMSA International Scientific Symposium. Antwerp, Belgium, April 17-19, 1996.


134. Rakocevic B, Glumac S, Dujmovic I. Correlation between ECG and

echocardiographic findings, dipyridamole test in patients with arterial hypertension. In:

Book of Abstracts of the 38th Yugoslav Medical Students' Congress. Kopaonik, Serbia,

April 23-27, 1996. P34. [Abstract in Serbian]

135. Pavlov S, Dujmovic I. Sepsis in patients with pemphigus vulgaris- the frequency

and main causes. In: Book of Abstracts of the 38th Yugoslav Medical Students' Congress.

Kopaonik, Serbia, April 23-27, 1996. P423. [Abstract in Serbian]

136. Dujmovic I. Cerebrospinal fluid findings in Alzheimer’s disease. In: Abstracts of the

1st European Medical Students’ Symposium. Athens, Greece, April 15-16, 1995. P102.


137. Dujmovic I. Routine cerebrospinal fluid findings in patients with multiple sclerosis.

In: Book of Abstracts of the 37th Yugoslav Medical Students' Congress. Vrnjacka Banja,

Serbia, April 24-28, 1995. pp127. [Abstract in Serbian]

138. Dujmovic I. Cerebrospinal fluid findings in patients with acute and chronic

inflammatory demyelinating polyradiculoneuropathy. In: Abstract Book of the 6th

European Students’ Conference for Students and Young Doctors. Berlin, Germany,

October 19-21, 1995. P77. [Abstract in English]

Products of Engaged Scholarship

Community-focused lectures:

1. Dujmovic I. What is brain swimming in? Brain Awareness Week, Belgrade, Serbia,

March 15, 2016 [Lecture in Serbian]

2. Dujmovic I. What is multiple sclerosis and what are the main causes of the disease?

Under Pressure Serbia Project, Belgrade, Serbia, March 26, 2014 [Lecture in Serbian]


3. Dujmovic I. What is multiple sclerosis? Brain Awareness Week, Belgrade, Serbia,

March 14, 2014 [Lecture in Serbian]

4. Dujmovic I. Barriers of the brain. Brain Awareness Week, Belgrade, Serbia, March

2013 [Lecture in Serbian]

5. Dujmovic I. Disease process in multiple sclerosis. Brain Awareness Week, Belgrade,

Serbia, March 17, 2011 [Lecture in Serbian]

6. Dujmovic I. Meet the Doctor- Workshops on Multiple Sclerosis; Clinic of Neurology,

Clinical Centre of Serbia, Belgrade, Serbia: May 30, 2014, February 27, 2015, December

14, 2016. [Lectures in Serbian]

Products of Creative Activity (Exhibitions)

Member of the Organizing Committee: "Under Pressure" exhibition with the aim to raise

public awareness of multiple sclerosis in Serbia organized at:

-The Gallery of Science and Technology of the Serbian Academy of Sciences,

Belgrade, Serbia, March 25-April 1, 2014.

-The Serbian National Parliament Hall, Belgrade, Serbia, April 3- April 11, 2014.

Digital and Other Novel Forms of Scholarship

1. Dujmovic I. What is the greatest clinical achievement in the field of multiple sclerosis

in the year of 2014 to your opinion? Clinic of Neurology, Clinical Centre of Serbia,

Belgrade, Serbia, June 25, 2015: a webinar [Lecture in Serbian]

2. Drulovic J, Mesaros S, Dujmovic I. National guidelines for the diagnosis and

treatment of multiple sclerosis. Clinic of Neurology, Clinical Centre of Serbia, Belgrade,

Serbia, November 20, 2014: a webinar. [Lecture in Serbian]

3. Dujmovic I. A rational approach to the cerebrospinal fluid diagnostics. Clinic of

Neurology, Clinical Centre of Serbia, Belgrade, Serbia, November 29, 2012: a webinar.

[Lecture in Serbian]

4. Dujmovic I. Multiple sclerosis relapse treatment algorithm. Clinic of Neurology,

Clinical Centre of Serbia, Belgrade, Serbia, June 7, 2012: a webinar. [Lecture in Serbian]

5. Dujmovic I. Clinically isolated syndrome and multiple sclerosis. Clinic of Neurology,

Clinical Centre of Serbia, Belgrade, Serbia, September 15, 2011: a webinar. [Lecture in

Serbian]

Refereed Unpublished Oral Presentations

1. Dujmovic Basuroski I. Neuromyelitis optica spectrum disorders: novel therapeutic

strategies. Pediatric Neuropsychiatry Section of the Serbian Medical Association Meeting.

Belgrade, Serbia, May 24, 2017: invited lecture [Lecture in Serbian].


2. Dujmovic Basuroski I. Clinical manifestations of the CNS demyelinating disorders.

CNS diseases affecting white and gray matter- a new insight into multiple sclerosis and

epilepsy: a continuing medical education course. Zlatibor, Serbia, May 18, 2017: invited

lecture [Lecture in Serbian]

3. Dujmovic Basuroski I. Challenges in the differential diagnosis of multiple sclerosis.

MSpedia: Medical Education Course in Multiple Sclerosis, Belgrade, Serbia, May 16,

2017: invited lecture [Lecture in Serbian].

4. Dujmovic Basuroski I. Survival in NMO Spectrum Disorders. Adriatic Neurology

Forum 2017, Opatija, Croatia, May 6, 2017: invited lecture. [Lecture in Serbian]

5. Dujmovic Basuroski I. Emerging Treatment Strategies for Neuromyelitis Optica

Spectrum Disorders. University of North Carolina at Chapel Hill: Grand Rounds, Chapel

Hill, NC, USA, October 27, 2016: invited lecture. [Lecture in English]

6. Dujmovic I. Neuroinflammation in multiple sclerosis and neuromyelitis optica

spectrum disorders: from microscopy to body fluid and MRI biomarkers. Regional

Biophysics School (NERKA 2016): Imaging Neuroinflammation, Kotor, Montenegro,

June 20, 2016: invited lecture. [Lecture in English]

7. Dujmovic I. Neuromyelitis optica spectrum disorders: current and future treatment

strategies. Adriatic Neurology Forum 2016, Becici, Montenegro, June 3, 2016: invited

lecture. [Lecture in Serbian]

8. Dujmovic I. Work capability in patients with multiple sclerosis. Adriatic Neurology

Forum 2016, Becici, Montenegro, June 3, 2016: invited lecture. [Lecture in Serbian]

9. Dujmovic I. Molecular biomarkers of treatment response in multiple sclerosis. The

XX Serbian Congress of Medicinal Biochemistry and Laboratory Medicine, Belgrade,

Serbia, May 27, 2016: invited lecture. [Lecture in Serbian]

10. Dujmovic I. Clinical presentation in patients with demyelinating CNS diseases.

Continuing Medical Education Course- Advances in demyelinating diseases of the CNS

and epilepsy. University of Belgrade School of Medicine, Belgrade, Serbia, April 22,

2016: invited lecture. [Lecture in Serbian]

11. Dujmovic I. Anti-aquaporin-4 antibodies as a marker of neuromyelitis optica spectrum

disorders. The 7th Meeting of the Immunological Society of Serbia, Belgrade, Serbia,

April 27, 2016: invited lecture. [Lecture in Serbian]

12. Dujmovic I. Therapeutic plasma exchange in neuromyelitis optica spectrum disorders.

Adriatic Forum 2015, Opatija, Croatia, September 17, 2015: invited lecture [Lecture in

Serbian]

13. Dujmovic I. NMO and NMO spectrum diseases. MS School, Palic, Serbia, September

5, 2015: invited lecture [Lecture in Serbian]

14. Dujmovic I. Prediction of CIS conversion to MS. MS School, Palic, Serbia,

September 4, 2015: invited lecture [Lecture in Serbian]


15. Dujmovic I. Biomarkers of treatment response in multiple sclerosis. The X/XVI

Congress of the Society of Serbian Neurologists with International Participation, Novi

Sad, Serbia, October 23, 2015: invited lecture [Lecture in Serbian]

16. Dujmovic I. Evidence-based symptomatic treatment in multiple sclerosis. Teaching

Course. The X/XVI Congress of the Society of Serbian Neurologists with International

Participation, Novi Sad, Serbia, October 22, 2015: invited lecture [Lecture in Serbian]

17. Dujmovic I. Biomarkers of disease progression and treatment response in multiple

sclerosis. The Day of the Clinic of Neurology Symposium, Belgrade, Serbia, October 12,

2015: invited lecture [Lecture in Serbian]

18. Dujmovic I. National guidelines of the good clinical practice: multiple sclerosis

Belgrade, Serbia, November 20, 2014: invited lecture [Lecture in Serbian]

19. Dujmovic I. Interferon beta and disability progression in relapsing-remitting multiple

sclerosis. The Day of the Clinic of Neurology Symposium, Belgrade, Serbia, October 10,


20. Dujmovic I. Body fluid biomarkers of the treatment response in multiple sclerosis.

Adriatic Neurology Forum & Danube Symposium for Neurological Sciences and

Continuing Education, Becici, Montenegro, April 26, 2014: invited lecture [Lecture in

Serbian]

21. Dujmovic I. Induction treatment in multiple sclerosis: from the patients perspective.

Satellite symposium (Merck).The IX /XV Congress of the Society of Serbian

Neurologists, Belgrade, Serbia, November 16, 2013: invited lecture [Lecture in Serbian]

22. Dujmovic I. Immunosuppressive treatment in neuromyelitis optica and multiple

sclerosis. Teaching Course. The IX /XV Congress of the Society of Serbian Neurologists

with International Participation, Belgrade, Serbia, November 14, 2013: invited lecture

[Lecture in Serbian]

23. Dujmovic I. National guidelines for the good clinical practice: Multiple sclerosis

Belgrade, Serbia, October 15, 2013: invited lecture [Lecture in Serbian]

24. Dujmovic I. Therapeutic plasma exchange in multiple sclerosis and neuromyelitis

optica. The new age in the inflammatory-demyelinating diseases of the central nervous

system. Continuing Medical Education Course, University of Belgrade School of

Medicine, Belgrade, Serbia, May 15, 2013: invited lecture [Lecture in Serbian]

25. Dujmovic I. Neuromyelitis spectrum disorders diagnosis. Tuzla Neurology

Symposium, Tuzla, Bosnia and Herzegovina, May 11, 2013: invited lecture [Lecture in

Serbian]

26. Dujmovic I. Biomarkers in multiple sclerosis: prediction of disease outcome and

treatment response. Adriatic Neurology Forum, Dubrovnik, Croatia, April 27, 2013:

invited lecture [Lecture in Serbian]


27. Dujmovic I. Multiple sclerosis as an indication for therapeutic plasma exchange.

Continuing Medical Education Course. Blood Transfusion Institute, Belgrade, Serbia,

November 8, 2012: invited lecture [Lecture in Serbian]

28. Dujmovic I. Methodological and laboratory approach in detection of multiple

sclerosis. Continuing Medical Education Course. The Centre for Medical Biochemistry,

Clinical Centre of Serbia, Belgrade, Serbia, September 27, 2012: invited lecture [Lecture

in Serbian]

29. Dujmovic I. National political developments in health and social care since 2003 in

Serbia. European Multiple Sclerosis Platform Congress, Barcelona, Spain, May 20, 2012:

invited lecture [Lecture in English]

30. Dujmovic I. Autoimmune aquaporinopathies. Doctoral Course-Autoimmune

Diseases, module Immunobiology, University of Belgrade School of Biology, Belgrade,

Serbia, May 4, 2012: invited lecture [Lecture in Serbian]

31. Dujmovic I. The diagnosis and treatment of neuromyelitis optica spectrum disorders.

Medical University of Ferrara, Italy, February 14, 2012: invited lecture [Lecture in

English]

32. Mesaros S, Pavlovic A, Basta I, Dujmovic Basuroski I, Radojcic A, Mijailovic M.

Clinical algoritms for the treatment of neurological diseases. Continuing Medical

Education Course. Clinic of Neurology, Clinical Centre of Serbia, November 28, 2011:


33. Dujmovic I. Diagnosis and treatment of neuromyelitis optica spectrum disorders.

Continuing Medical Education Course: New diagnostic and therapy approach in multiple

sclerosis, University of Belgrade School of Medicine, Belgrade, Serbia, November 7,


34. Dujmovic I. Diagnosis and treatment of neuromyelitis optica. The VIII/XIV Congress

of the Society of Serbian Neurologists with International Participation, Kopaonik, Serbia,

October 1, 2011: invited lecture [Lecture in Serbian]

35. Dujmovic I. Neuropsychiatric manifestations of systemic lupus erythematosus and

Sjögren's syndrome-diagnosis and treatment. Teaching Course. The VIII/XIV Congress of

the Society of Serbian Neurologists with International Participation, Kopaonik, Serbia,

October 1, 2011: invited lecture [Lecture in Serbian]

36. Dujmovic I. The significance of anti-aquaporin 4 antibodies in neurological diseases.

Serbian Medical Association Neurology Symposium, Belgrade, Serbia, December 2010:


37. Dujmovic I. Neutralizing anti-interferon beta antibodies in patients with multiple

sclerosis. Lessions of The Clinic of Neurology, Belgrade, Serbia, October 6, 2010: invited

lecture [Lecture in Serbian]

38. Dujmovic I. Clinical and molecular biomarkers in the prediction of treatment

response in multiple sclerosis. Serbia and Montenegro Neurology Symposium, Becici,

Montenegro, September 30, 2010: invited lecture [Lecture in Serbian]


39. Dujmovic I. Natural course of multiple sclerosis-the significance of cohort studies.

The VII/XIII Congress of the Society of Serbian Neurologists with International

Participation, Kragujevac, Serbia, September 12, 2008: invited lecture [Lecture in

Serbian]

40. Dujmovic I. The significance of uric acid in multiple sclerosis. The 2nd

Joint

Symposium of Serbian and Hungarian Neurologists, Belgrade, October 20, 2007: invited

lecture [Lecture in English]

41. Dujmovic I. The population registry, incidence, prevalence and natural course of

multiple sclerosis in Belgrade. Balkan Neurology Symposium, Zlatibor, Serbia, June 22,

2007: invited lecture. [Lecture in Serbian]

6) Teaching activities:

Faculty Member (Lecture: Pathogenesis of multiple sclerosis), Course- Trends in

Neurohistology, University of Belgrade School (now- Faculty) of Medicine, Belgrade,

Serbia: 2016- 2017

Graduate Dissertation Mentor for medical students, University of Belgrade School

(now- Faculty) of Medicine, Belgrade, Serbia: 2015- 2017(three students)

Mentor, Specialization in Laboratory Medicine (Course- Neuroimmunology), University

of Belgrade School (now- Faculty) of Medicine, Belgrade, Serbia: 2014- 2017

Faculty Member (seminars), Postgraduate Course in Neuroetics, University of Belgrade

School (now- Faculty) of Medicine, Belgrade, Serbia: 2014- 2017

Faculty Member (Lecture: Prognostic models in multiple sclerosis), Postgraduate Course

in Clinical Epidemiology, University of Belgrade School of Medicine, Belgrade, Serbia:

2014- 2016

Research Mentor for undergraduate medical students: 2012- 2017 (six students)

Clinical Assistant Professor of Neurology (student preceptorship, mid-term neurology

exams, final neurology test exams, final neurology practical exams), University of

Belgrade School (now- Faculty) of Medicine, Department of Neurology, Belgrade,

Serbia: 2011- 2017

Lecturer (Lecture: Autoimmune aquaporinopathies), Postgraduate Course in

Immunology, University of Belgrade Faculty of Biology, Belgrade, Serbia, March 2011

Lecturer (lectures, cases presentations, seminars), Courses: Specialization in Neurology,

Specialization in General Medicine, Specialization in Emergency Medicine, University of

Belgrade School (now- Faculty) of Medicine, Belgrade, Serbia: 2002-2017

Presenter: Grand Rounds, Clinic of Neurology, Clinical Centre of Serbia, Belgrade,

Serbia:1997- 2017


7) Grants:

Project team member (2013-2014)

Project: Creating Advocacy Strategy for Neurosciences in Serbia.

Funded by: Federation of European Neuroscience Societies

Researcher (2010- 2017)

Project: A comparative analysis of clinical parameters and biomarkers in the prognosis

of disease evolution in multiple sclerosis and other immune-mediated neurological

diseases.

Funded by: Serbian Ministry of Education, Science and Technological Development

Research Fellow (Jan-Mar 2010)

Project: Antibodies to interferon-beta.

Funded by: Innsbruck Medical University, Innsbruck, Austria

Research Fellow (Jan-Dec 2009)

Fellowship: “ Prof. Risto Bokonjic Foundation “ (for post-doc research in

neuroimmunology at the Innsbruck Medical University, Innsbruck, Austria)

Researcher (2007-2008)

Project: Quality of life in patients with neurological diseases.

Funded by: Serbian Ministry of Education, Science and Technological Development

Junior Travelling Fellow (2003)

Fellowship: World Federation of Neurology


Project: Correlation of clinical characteristics and markers of inflammation,

demyelination and axonal loss in multiple sclerosis and Guiilain Barré syndrome.

Funded by: Serbian Ministry of Science and Technology


Project: Integrative functions of the nervous system.

Funded by: Serbian Ministry of Science and Technology

Postgraduate Fellow (1997-1999)

Fellowship: Serbian Ministry of Science and Technology Fellowship for Postgraduate

Studies

8) Professional Service:

a) Memberships

Member (2017-)

American Academy of Neurology


Member (2016- present)

International Clinical Consortium ,The Guthy- Jackson Charitable Foundation


European Academy of Neurology Scientific Panel on Neuro-ophthalmology & Neuro-

otology

Council Member (2014- present)

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Secretary-General (2014- 2017)

Multiple Sclerosis Task Force of the Society of Serbian Neurologists


The European Consortium for Cerebrospinal Fluid Biomarker Research in Multiple

Sclerosis (BioMS, www. biomseu.com)

President (2004-2005)

The European Association of Young Neurologists and Trainees

President-Elect (2003-2004)

The European Association of Young Neurologists and Trainees

National Co-ordinator for Yugoslavia (1995-1997)

The European Medical Students’ Association (EMSA).

b) Editorial Appointments

Editorial Board Member (2012-2014)

ISRN Neuroscience

Associate Editor (1996-1997)

Journal of the European Medical Students’ Association (JEMSA).

Editorial Board Member (1995-1997)

Medical Youth, The Medical Student Scientific Journal at the University of Belgrade

School of Medicine, Belgrade, Serbia

c) Ad Hoc Reviewer (2010- present)

PLOS One, Neurological Research, Clinical Neurology and Neurosurgery, Experimental

Neurology, ISRN Neuroscience, Journal of Neurological Sciences, European Journal of

Neurology, Clinical Chemistry and Laboratory Medicine, Autoimmune Diseases, Case

Reports in Medicine, Neurologia Croatica, Future Neurology, Multiple Sclerosis and

Related Disorders, BMJ Case Reports.


d) Consultancy service within institution:

Member (2006- 2017)

Expert Commission for Disease- Modifying Treatment in Multiple Sclerosis, Clinic of

Neurology, Clinical Centre of Serbia, Belgrade, Serbia

e) Consultancy services outside institution:

Member (2010- 2017)

Multiple Sclerosis Society of Serbia Advisory Board

Advisor, Betaferon Advisory Board Meeting, Vienna, Austria, June 2016

Chapel Hill, NC, November 25, 2017

irena dujmovic basuroski - unc health care...knjazevac gymnasium, knjazevac, serbia 1986-1990. 5)...

Documents